Cellectis (CLLS) Short-term Investments (2013 - 2026)

Cellectis' Short-term Investments history runs 11 years deep, the most recent figure standing at $150.8 million for Q1 2026.

• In Q1 2026, Short-term Investments rose 29.96% year-over-year to $150.8 million; the TTM figure through Mar 2026 stood at $150.8 million (up 29.96% YoY), while the FY2025 annual figure was $147.1 million, down 44.45% from the prior year.
• Short-term Investments for Q1 2026 stood at $150.8 million, up from $147.1 million in the prior quarter.
• The five-year high for Short-term Investments was $264.9 million in Q4 2024, with the low at $499000.0 in Q1 2022.
• The 5-year median for Short-term Investments is $109.2 million (2022), against an average of $102.2 million.
• Peak annual rise in Short-term Investments reached 20423.65% in 2022, while the deepest fall reached 97.29% in 2022.
• Cellectis' Short-term Investments stood at $102.4 million in 2022, then jumped by 103.56% to $208.5 million in 2023, then increased by 27.05% to $264.9 million in 2024, then plunged by 44.45% to $147.1 million in 2025, then advanced by 2.51% to $150.8 million in 2026.
• Business Quant data shows CLLS's Short-term Investments at $150.8 million in Q1 2026, $147.1 million in Q4 2025, and $140.0 million in Q3 2025.